Advertisement
Screener

VERU INC. (VERU) Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised

2.8 / 5 stars · 68/120 Roast Me

VERU INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised

VERU INC. (VERU) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised of 1.56 million shares for the 12-month period ending 2012-09-30, per its 10-K filed 2012-12-04.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised · last filed 2013-12-03

  • VERU INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2012 was 1.56M shares.
  • VERU INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2011 was 0.00 shares, a 100.00% decline from fiscal 2010.
  • VERU INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2010 was 626.50K shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 12 month
2012-09-301.56M shares
10-K · filed 2012-12-04
2011-09-300.00 shares
10-K · filed 2013-12-03
2010-09-30626.50K shares
10-K · filed 2012-12-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kairos Pharma, LTD. (KAPA)United States$0.041B
SCYNEXIS INC (SCYX)United States$0.045B
PDS Biotechnology Corp (PDSB)United States$0.045B
Incannex Healthcare Inc. (IXHL)$0.040B-22.32
Grace Therapeutics, Inc. (GRCE)$0.046B-1.83
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98
Edesa Biotech, Inc. (EDSA)Canada$0.039B
Werewolf Therapeutics, Inc. (HOWL)United States$0.047B
CervoMed Inc. (CRVO)United States$0.038B-1.39
Celularity Inc (CELU)United States$0.038B-0.34